Literature DB >> 2315370

Corticostriatal and thalamic regulation of amphetamine-induced ascorbate release in the neostriatum.

A Basse-Tomusk1, G V Rebec.   

Abstract

Lesions of cerebral cortex and ventromedial nucleus (VM) of the thalamus were made in rats to investigate the contribution of these structures to amphetamine (AMPH)-induced ascorbate (AA) release in the neostriatum as measured by in vivo voltammetry. Following a recovery period of at least one week, rats were anesthetized, and electrochemically modified, carbon-fiber electrodes were lowered into the neostriatum. Compared to data obtained from sham-operated and unoperated controls, bilateral aspiration lesions of cerebral cortex significantly lowered both the basal level of AA and the amount of AA released by AMPH in the neostriatum. Similar results were obtained after bilateral, but not unilateral electrolytic lesions of the VM thalamus. Collectively, these results suggest that the corticostriatal pathway and the VM thalamic nuclei participate in the regulation of basal and AMPH-induced AA release in the neostriatum.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2315370     DOI: 10.1016/0091-3057(90)90204-u

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  9 in total

1.  A comparative study between a brain Na+,K(+)-ATPase inhibitor (endobain E) and ascorbic acid.

Authors:  G Rodríguez de Lores Arnaiz; T Herbin; C Peña
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

2.  On the mechanism of d-amphetamine-induced changes in glutamate, ascorbic acid and uric acid release in the striatum of freely moving rats.

Authors:  M Miele; M A Mura; P Enrico; G Esposito; P A Serra; R Migheli; D Zangani; E Miele; M S Desole
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

Review 3.  Ascorbic Acid to Manage Psychiatric Disorders.

Authors:  Morgana Moretti; Daiane Bittencourt Fraga; Ana Lúcia S Rodrigues
Journal:  CNS Drugs       Date:  2017-07       Impact factor: 5.749

4.  Corticostriatal dysfunction underlies diminished striatal ascorbate release in the R6/2 mouse model of Huntington's disease.

Authors:  Jenelle L Dorner; Benjamin R Miller; Emma L Klein; Alexander Murphy-Nakhnikian; Rachel L Andrews; Scott J Barton; George V Rebec
Journal:  Brain Res       Date:  2009-07-16       Impact factor: 3.252

5.  Behavioral activation in rats requires endogenous ascorbate release in striatum.

Authors:  G V Rebec; Z Wang
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

6.  Up-regulation of GLT1 reverses the deficit in cortically evoked striatal ascorbate efflux in the R6/2 mouse model of Huntington's disease.

Authors:  Benjamin R Miller; Jenelle L Dorner; Kendra D Bunner; Thomas W Gaither; Emma L Klein; Scott J Barton; George V Rebec
Journal:  J Neurochem       Date:  2012-03-28       Impact factor: 5.372

7.  Dysregulation of corticostriatal ascorbate release and glutamate uptake in transgenic models of Huntington's disease.

Authors:  George V Rebec
Journal:  Antioxid Redox Signal       Date:  2013-06-19       Impact factor: 8.401

Review 8.  Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2.

Authors:  Fiona E Harrison; James M May
Journal:  Free Radic Biol Med       Date:  2009-01-06       Impact factor: 7.376

9.  Repeated treatment with ascorbate or haloperidol, but not clozapine, elevates extracellular ascorbate in the neostriatum of freely moving rats.

Authors:  R C Pierce; A J Clemens; L A Shapiro; G V Rebec
Journal:  Psychopharmacology (Berl)       Date:  1994-09       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.